Philips releases new software for faster, more accurate delivery of cancer treatments.

Read original

Philips releases new software for faster, more accurate delivery of cancer treatments. September 7, 2002 Royal Philips Electronics (NYSE: PHG, AEX: PHI) announced today a new software release for the Pinnacle3 Radiation Therapy System and a new planning workstation. The Pinnacle Pro SunBlade 2000? workstation, provided with P3IMRT version 1.2b, will enable physicians to plan Intensity Modulated Radiation Therapy (IMRT) for cancer patients more accurately, allowing for faster and more efficient delivery of treatments. IMRT is a noninvasive procedure that allows for the pinpoint delivery of radiation therapy to the patient by using a computer system to change the intensity of radiation beams to create a clinically optimized treatment plan - one that maximizes dose to the tumor while sparing the normal tissues. "Philips' integrated line of radiation oncology products draws on more than 25 years of clinical and technological expertise combined with the resources of Royal Philips Electronics to offer clinicians complete oncology solutions," said Ian Farmer, general manager, Philips Radiation Oncology Systems, Philips Medical Systems. "Our new workstation arms oncologist's, dosimetrists, physicists, and administrators with the tools to elevate the level of clinical excellence provided to patients." P3IMRT, in combination with the new Sun Blade workstations brings a new level of performance to IMRT treatment planning. The Sun Blade is the industry's first 1-GHz 64-bit workstation, providing leading-edge computing performance and high-end 3D visualization. It uses a Superscalar, 64-bit, high-performance UltraSPARC III Cu CPU. Also included is the Solaris? 8 operating system, designed for multiprocessing and 64-bit computing. This new operating system scales to handle evolving security requirements as well as heavy network traffic, huge data sets, and compute-intensive problems. Using the Sun Blade with P3IMRT, clinicians will be able to optimize most plans, including 9-beam head and neck treatments, in about 20 minutes. Current users will also see significant improvements in performance. The new software is compatible with all existing Pinnacle3 IMRT planning systems. "There has been an exceptionally high demand for our IMRT product. The number of cancer centers that are implementing P3IMRT in the clinic has grown rapidly to more than 300 sites worldwide," said Harry Tschopik, director of global marketing, Philips Radiation Oncology Systems, Philips Medical Systems. "It is significant that our product offers full connectivity to R&V systems and accelerators from all major vendors, including Varian, Elekta, Siemens, Mitsubishi and IMPAC." The PROS IMRT planning software was developed in partnership with RaySearch Laboratories AB, Stockholm, Sweden. Along with P3IMRT, Philips Radiation Oncology Systems offers other best- in-class solutions for oncology including AcQSimCT (the only oncology- dedicated 85 cm bore CT), AcQSim (the leading CT Simulation workstation), and Pinnacle3 (the only fully-integrated workstation with CT Simulation, 3D planning and IMRT). For further information please contact: USA: Janet Collins Tel: +1 425 482 8547 janet.collins@philips.com Heidi Wilson Tel: +1 978 659 7302 heidi.wilson@philips.com Europe: Diana van Dongen Tel: +31 40 27 64718 mdiana.van.dongen@philips.com Royal Philips Electronics of the Netherlands is one of the world's biggest electronics companies and Europe's largest, with sales of EUR 32.3 billion in 2001. It is a global leader in color television sets, lighting, electric shavers, medical diagnostic imaging and patient monitoring, and one-chip TV products. Its 184,000 employees in more than 60 countries are active in the areas of lighting, consumer electronics, domestic appliances, components, semiconductors, and medical systems. Philips is quoted on the NYSE (symbol: PHG), London, Frankfurt, Amsterdam and other stock exchanges. News from Philips is located at www.philips.com/newscenter. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/02/06/20040206BIT00440/wkr0001.doc http://www.waymaker.net/bitonline/2004/02/06/20040206BIT00440/wkr0002.pdf

About Us

RaySearch Laboratories AB (publ) has been pushing the limits of advanced cancer treatment since 2000. Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world. The algorithms are based upon founder and CEO Johan Löf’s scientific knowledge, acquired during his PhD on radiation treatment of moving tumors at the Karolinska Institute. The treatment planning system RayStation and the OIS RayCare are the result of extensive development during years of research, and today used to improve chances of survival and quality of life for cancer patients. We fight for a world where cancer is conquered.

Subscribe